Successful treatment of excessive daytime sleepines... [J Neurol. 2001] - PubMed

loading

Modafinil for the treatment of daytime sleepiness in Parkinson's disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial. [Sleep. 2002]
Modafinil for the treatment of daytime sleepiness in Parkinson's disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial.
Högl B, Saletu M, Brandauer E, Glatzl S, Frauscher B, Seppi K, Ulmer H, Wenning G, Poewe W. Sleep. 2002 Dec; 25(8):905-9.
Review Modafinil in the treatment of excessive daytime sleepiness. [Cleve Clin J Med. 2007]
Review Modafinil in the treatment of excessive daytime sleepiness.
Valentino RM, Foldvary-Schaefer N. Cleve Clin J Med. 2007 Aug; 74(8):561-6, 568-71.
Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson's disease. [Mov Disord. 2003]
Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson's disease.
Adler CH, Caviness JN, Hentz JG, Lind M, Tiede J. Mov Disord. 2003 Mar; 18(3):287-93.
Modafinil for excessive daytime sleepiness in myotonic dystrophy. [Neurology. 2001]
Modafinil for excessive daytime sleepiness in myotonic dystrophy.
Damian MS, Gerlach A, Schmidt F, Lehmann E, Reichmann H. Neurology. 2001 Mar 27; 56(6):794-6.
Review Why choose modafinil for excessive daytime sleepiness? [Issues Ment Health Nurs. 2007]
Review Why choose modafinil for excessive daytime sleepiness?
Tobin ML. Issues Ment Health Nurs. 2007 Mar; 28(3):313-7.

Review Present and future drug treatment for Parkinson's disease. [J Neurol Neurosurg Psychiatry....]
Review Present and future drug treatment for Parkinson's disease.
Schapira AH. J Neurol Neurosurg Psychiatry. 2005 Nov; 76(11):1472-8.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Successful treatment of excessive daytime sleepiness in Parkinson's disease with...
Successful treatment of excessive daytime sleepiness in Parkinson's disease with modafinil.
J Neurol. 2001 Jul ;248(7):632-4.

PubMed
Cholesterol: precursor to many lipid disorders.
Cholesterol: precursor to many lipid disorders.
Am J Manag Care. 2001 Aug ;7(9 Suppl):S289-98.

PubMed
Cloning and characterization of PIMT, a protein with a methyltransferase domain,...
Cloning and characterization of PIMT, a protein with a methyltransferase domain, which interacts with and enhances nuclear receptor coactivator PRIP function.
Proc Natl Acad Sci U S A. 2001 Aug 28 ;98(18):10380-5. Epub 2001 Aug 21 .

PubMed
A monoclonal cytolytic T-lymphocyte response observed in a melanoma patient vacc...
A monoclonal cytolytic T-lymphocyte response observed in a melanoma patient vaccinated with a tumor-specific antigenic peptide encoded by gene MAGE-3.
Proc Natl Acad Sci U S A. 2001 Aug 28 ;98(18):10290-5. Epub 2001 Aug 21 .

PubMed
p35 and p39 are essential for cyclin-dependent kinase 5 function during neurodev...
p35 and p39 are essential for cyclin-dependent kinase 5 function during neurodevelopment.
J Neurosci. 2001 Sep 1 ;21(17):6758-71.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed